Ekso Bionics (EKSO) Earning Somewhat Critical News Coverage, Report Finds

News coverage about Ekso Bionics (NASDAQ:EKSO) has been trending somewhat negative recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Ekso Bionics earned a media sentiment score of -0.03 on Accern’s scale. Accern also gave headlines about the company an impact score of 45.0549921819118 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

These are some of the media stories that may have effected Accern’s rankings:

A number of research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Ekso Bionics from a “sell” rating to a “hold” rating in a research report on Tuesday, January 9th. ValuEngine upgraded shares of Ekso Bionics from a “strong sell” rating to a “sell” rating in a research report on Friday, November 17th.

Shares of Ekso Bionics (NASDAQ EKSO) traded down $0.13 during trading hours on Wednesday, hitting $1.58. 460,917 shares of the company’s stock were exchanged, compared to its average volume of 492,330. Ekso Bionics has a 1 year low of $0.99 and a 1 year high of $4.77. The firm has a market cap of $102.97, a price-to-earnings ratio of -1.70 and a beta of 1.34. The company has a debt-to-equity ratio of 0.18, a quick ratio of 5.73 and a current ratio of 6.09.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://sportsperspectives.com/2018/03/14/ekso-bionics-ekso-earning-somewhat-critical-news-coverage-report-finds.html.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness.

Insider Buying and Selling by Quarter for Ekso Bionics (NASDAQ:EKSO)

Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply